Bausch Health Companies Inc. Liability for Uncertainty in Income Taxes, Noncurrent
Bausch Health Companies Inc. (BHC) had Liability for Uncertainty in Income Taxes, Noncurrent of $265.00 million as of 2017-09-30, per its 10-Q filed 2017-11-07.
Discontinued › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:LiabilityForUncertainTaxPositionsNoncurrent · last filed 2017-11-07
- 2017-09-30: Liability for Uncertainty in Income Taxes, Noncurrent $265.00M.
- 2017-06-30: Liability for Uncertainty in Income Taxes, Noncurrent $258.00M.
- 2017-03-31: Liability for Uncertainty in Income Taxes, Noncurrent $253.00M.
- 2016-12-31: Liability for Uncertainty in Income Taxes, Noncurrent $184.00M.
| Period end | Liability for Uncertainty in Income Taxes, Noncurrent | Liability for Uncertainty in Income Taxes, Noncurrent as first filed |
|---|---|---|
| 2017-09-30 | $265.00M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $258.00M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $253.00M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $184.00M 10-Q · filed 2017-11-07 | |
| 2016-09-30 | $112.30M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $116.30M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $117.70M 10-Q · filed 2016-06-07 | |
| 2015-12-31 | $120.00M 10-K · filed 2017-03-01 | $120.20M 10-K · filed 2016-04-29 |
| 2015-09-30 | $109.30M 10-Q · filed 2015-10-26 | |
| 2015-06-30 | $101.20M 10-Q · filed 2015-07-28 | |
| 2015-03-31 | $98.70M 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $102.60M 10-K · filed 2016-04-29 | |
| 2014-09-30 | $113.80M 10-Q · filed 2014-10-24 | |
| 2014-06-30 | $115.80M 10-Q · filed 2014-08-01 | |
| 2014-03-31 | $98.60M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $169.10M 10-K · filed 2015-02-25 | $169.12M 10-K · filed 2014-02-28 |
| 2013-09-30 | $159.67M 10-Q · filed 2013-11-01 | |
| 2013-06-30 | $105.77M 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $107.02M 10-Q · filed 2013-05-03 | |
| 2012-12-31 | $103.66M 10-K · filed 2014-02-28 | |
| 2012-09-30 | $99.54M 10-Q · filed 2012-11-05 | |
| 2012-06-30 | $95.94M 10-Q · filed 2012-08-03 | |
| 2012-03-31 | $102.03M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $91.10M 10-K · filed 2013-02-28 | |
| 2011-09-30 | $103.21M 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $101.80M 10-Q · filed 2011-08-08 | |
| 2011-03-31 | $99.96M 10-Q · filed 2011-05-10 | |
| 2010-12-31 | $96.10M 10-K · filed 2012-02-29 | |
| 2010-09-30 | $93.66M 10-Q · filed 2010-11-05 | |
| 2010-06-30 | $66.90M 10-Q · filed 2010-08-06 | |
| 2009-12-31 | $66.20M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |